GI
PCRX icon

GAMMA Investing’s Pacira BioSciences PCRX Stock Holding History

GAMMA Investing’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.2K Sell
2,371
-460
-16% -$10.9K ﹤0.01% 2177
2026
Q1 		$64K Sell
2,831
-176
-6% -$3.91K ﹤0.01% 2007
2025
Q4 		$77.8K Sell
3,007
-18
-0.6% -$428 ﹤0.01% 1759
2025
Q3 		$78K Sell
3,025
-669
-18% -$16.4K ﹤0.01% 1688
2025
Q2 		$88.3K Hold
3,694
– – 0.01% 1549
2025
Q1 		$91.8K Buy
3,694
+1,958
+113% +$46.9K 0.01% 1333
2024
Q4 		$32.7K Buy
1,736
+179
+11% +$3.14K ﹤0.01% 1986
2024
Q3 		$23.4K Buy
1,557
+219
+16% +$3.74K ﹤0.01% 2014
2024
Q2 		$38.3K Buy
1,338
+932
+230% +$26.5K 0.01% 1381
2024
Q1 		$11.9K Buy
406
+286
+238% +$8.79K ﹤0.01% 1966
2023
Q4 		$3.91K Buy
+120
New +$3.51K ﹤0.01% 2340

Other funds holding PCRX

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return